Dereume J P, van Romphey A, Vincent G, Engelmann E
Department of Vascular Surgery, Free University of Brussels (ULB), Belgium.
Cardiovasc Surg. 1993 Oct;1(5):499-503.
A new, compliant, highly porous, non-woven, polyurethane vascular prosthesis has been developed in an effort to improve on the performance of currently available prosthetic grafts for infrainguinal reconstruction. From April 1990 to August 1991, 57 femoropopliteal bypass grafts were implanted in 47 patients by surgeons at five university centres. In all instances, the saphenous vein was unavailable, unusable or reserved for use elsewhere. An empirical perioperative risk score for acute occlusion (0-20) was developed, based on such factors as severity of clinical ischaemia, quality of inflow and outflow, site of distal anastomosis and associated drug therapy. Primary cumulative patency was calculated according to standard life-table analysis. Poor inflow and a distal anastomosis below the knee were significant factors affecting graft patency (P = 0.001 and P = 0.001 respectively). Six-month cumulative patency for the 25 grafts with good inflow and above or mid-knee anastomoses (79%) was superior to the cumulative patency for all 57 grafts (59%). There was a significant improvement in patency rates between 'low' (22 grafts) and 'medium risk' (27 grafts) patients and 'high risk' (eight grafts) ones (risk scores 0-10 and 11-20 respectively) at a level of P = 0.001. There were two operative deaths (4%). Of the 19 postoperative occlusions, six occurred within 30 days and 18 within 6 months. These data indicate that the patency rates achieved with this new graft compare favourably with other available prosthetic grafts. In addition, the graft demonstrates superior handling characteristics and eliminates bleeding through suture holes.(ABSTRACT TRUNCATED AT 250 WORDS)
为了改进目前用于腹股沟下重建的人工血管移植物的性能,已研发出一种新型的、符合要求的、高度多孔的非织造聚氨酯血管假体。1990年4月至1991年8月,五个大学中心的外科医生为47例患者植入了57条股腘动脉搭桥移植物。在所有病例中,大隐静脉无法获取、不可用或留作他用。基于临床缺血严重程度、流入和流出质量、远端吻合部位及相关药物治疗等因素,制定了急性闭塞的经验性围手术期风险评分(0 - 20分)。根据标准寿命表分析计算原发性累积通畅率。流入不佳和膝下远端吻合是影响移植物通畅率的重要因素(分别为P = 0.001和P = 0.001)。25条流入良好且吻合位于膝上或膝中部的移植物的6个月累积通畅率(79%)高于所有57条移植物的累积通畅率(59%)。“低风险”(22条移植物)、“中等风险”(27条移植物)和“高风险”(8条移植物)患者(风险评分分别为0 - 10分和11 - 20分)之间的通畅率在P = 0.001水平上有显著改善。有2例手术死亡(4%)。19例术后闭塞中,6例发生在30天内,18例发生在6个月内。这些数据表明,这种新型移植物的通畅率与其他现有人工血管移植物相比具有优势。此外,该移植物显示出优越的操作特性,并消除了缝合孔出血。(摘要截短于250字)